secwatch.observer — SEC 8-K summary
======================================

Issuer:     Caribou Biosciences, Inc. (CRBU)
CIK:        0001619856
Form:       8-K
Filed at:   2026-06-18T20:02:21+00:00
Accession:  0001619856-26-000047
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Caribou Biosciences shareholders reject officer exculpation amendment at annual meeting
--------------------------------------------------------------------------------

- Proposal 3 (officer exculpation) failed: 37.5M for, 3.5M against, 27.1M broker non-votes.
- Three Class II directors elected: Guggenhime, Johnson, Whiting with ~31.6M votes each.
- Ratification of Deloitte as auditor approved: 67.5M for, 0.3M against.
- Adjournment proposal approved but company chose not to adjourn to solicit more votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1619856/000161985626000047/0001619856-26-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1619856/000161985626000047/crbu-20260617.htm
  HTML page:      https://secwatch.observer/filing/0001619856-26-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer